Drug Eluting Stent Market 2021-2027 Trends, Research Report, Growth Trends, Opportunities, Forecast to 2027

The Drug-Eluting Stents Market size is expected to grow at an annual average of 7% during 2021-2027. A drug-eluting stent (DES) is a peripheral or coronary stent that is inserted into a narrowed or diseased peripheral or coronary artery that slowly releases a drug to block cell proliferation. Drug-eluting stents are coated with a drug that is released (eluted) to prevent the growth of scar tissue in the arterial wall. The eluted drug keeps the arteries smooth and exposed, ensuring proper blood flow and reducing the likelihood of restenosis. DES is considered the gold standard in the treatment of coronary heart disease because it offers numerous benefits such as improved vascular healing, minimal invasiveness, and reduced need for long-term double antiplatelet therapy. Patients who have had DES transplanted are encouraged to use certain drugs or drug regimens. This therapy helps to reduce the risk of thrombosis in the stent due to the relatively slow healing process.

Drug Eluting Stent Market Segmentation

By Coating

• Polymer Based Coating
• Biodegradable
• Non-Biodegradable
• Polymer Free Coating
• Microporous Surface
• Microstructured Surface
• Slotted Tubular Surface
• Nanoporous Surface

By Application

• Coronary Artery Disease
• Peripheral Artery Disease

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

Major Players

• Boston Scientific Corporation
• Terumo Corporation
• Abbott Laboratories
• Medtronic Plc
• Biotronik SE & Co. KG

Key Questions Answered by Drug Eluting Stent Market Report

• What was the Drug Eluting Stent Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
• What will be the CAGR of Drug Eluting Stent Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Drug Eluting Stent Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume